Recent animal trials conducted by Kiran Musunuru and William Peranteau show that prenatal molecular tools can access the heart and other hard-to-reach muscles, potentially enabling in utero treatment for Duchenne muscular dystrophy. The proposed procedure mirrors standard fetal blood transfusions through the umbilical vein, avoiding the risks of open fetal surgery. Furthermore, scientists are deploying lipid nanoparticles rather than inactivated viruses to safely transport CRISPR components through fetal circulation. However, clinical applications remain at least three years away as researchers address unresolved challenges such as crossing the blood-brain barrier.
Key points
Human clinical trials for prenatal gene editing remain at least three years away despite…: Human clinical trials for prenatal gene editing remain at least three years away despite encouraging animal research.
Treatments currently target only non-reproductive somatic cells to deliberately avoid eth…: Treatments currently target only non-reproductive somatic cells to deliberately avoid ethical controversies associated with heritable genetic alterations.
Neurological disorders cannot yet be addressed because existing prenatal therapies are in…: Neurological disorders cannot yet be addressed because existing prenatal therapies are incapable of bypassing the blood-brain barrier.
Sources checked by our analysis pipeline: 1
One of the keys to curing a rare disease is treating patients early. But what if you treated them before they were born?
Over the past decade, several researchers have pursued this provocative idea. Now, they are starting to make meaningful progress in fetal gene editing, an approach that holds the potential to stop genetic disorders before it's too late.
"If you really want to prevent the worst ravages of the disease, you can't wait until they're born," said Kiran Musunuru, a gene editing expert at the University of Pennsylvania. "You've got to go in utero."
The futuristic technique is benefiting from new advances in prenatal diagnostics and CRISPR, the Nobel Prize-winning DNA editing tool. Other scientists pursuing the idea include David Stitelman at the Yale School of Medicine, Tippi MacKenzie at University of California, San Francisco, and Aijun Wang, a biomedical engineer at UC Davis.
For more stories like this, sign up for the CNBC Cures newsletter.
Musunuru made headlines is 2025 when he helped develop the world's first personalized gene editing treatment for an infant with a rare…
Researchers analyzing sediment cores from ancient Maya cities in the Yucatan peninsula determined that the sacred red pigment cinnabar severely poisoned local freshwater ecosystems for centuries. This mineral leached from decorative murals and tombs into lakes, drastically devastating aquatic food chains and presenting chronic health risks to nearby populations. These toxic concentrations may have acted as an insidious, long-term stressor alongside regional climate shifts and social conflicts.
Researchers analyzing the limb bones of an ancient Brazilian theropod have detected chemical signatures of hemoglobin-derived heme molecules and collagen-linked amino acids. The discovery challenges established scientific assumptions regarding the maximum survival lifespan of fragile biological structures. These insights suggest that properly preserved fossils could hold overlooked molecular records that aid in studying extinct species and extraterrestrial life.
Researchers documented an unusual case of colony survival where an isolated population persevered despite complete entrapment. The insects sustained themselves solely by consuming fellow colony members over an extended period. This observation highlights extreme dietary adaptation under conditions of total environmental confinement.